Colgate-Palmolive reports EPS in-line, misses on revs; expects a low-single digit net sales increase for FY17 :
- Reports Q4 (Dec) earnings of $0.75 per share, excluding $0.06 per diluted share of aftertax charges resulting from the Company's Global Growth and Efficiency Program and an aftertax charge of $0.01 per diluted share for a previously disclosed litigation matter, in-line with the Capital IQ Consensus of $0.75; revenues fell 4.6% year/year to $3.72 bln vs the $3.87 bln Capital IQ Consensus.
- Gross profit margin was 60.4% in fourth quarter 2016 versus 58.8% in fourth quarter 2015. Excluding charges from the 2012 Restructuring Program in both periods, Gross profit margin was 60.8% in fourth quarter 2016, an increase of 180 basis points versus the year ago quarter.
- Guidance:
- "As we look ahead, uncertainty in global markets and foreign exchange volatility remain challenging, which sees us redoubling our focus on profitable growth. While based on current spot rates, we expect a low-single-digit net sales increase for 2017, we anticipate another year of solid organic sales growth driven by a full new product pipeline, engaging marketing programs and strong advertising support. "On a GAAP basis, based on current spot rates, we are planning for a year of gross margin expansion and expect earnings per share on a dollar basis to be flat. "Excluding charges related to the 2012 Restructuring Program and the other 2016 one-time items noted above, based on current spot rates, we are planning for a year of strong operating cash flow, gross margin expansion and increased advertising investment and expect low-single-digit earnings per share growth on a dollar basis."
- "Excluding charges related to the 2012 Restructuring Program and the other 2016 one-time items noted above, based on current spot rates, we are planning for a year of strong operating cash flow, gross margin expansion and increased advertising investment and expect low-single-digit earnings per share growth on a dollar basis."
No comments:
Post a Comment